The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced preclinical data highlighting an ...

Lake Erie College of Osteopathic Medicine (LECOM) is reinforcing its commitment to accessible and affordable pharmacy ...

For years, pomegranates have enjoyed a reputation as a "heart-healthy" fruit. As a cardiovascular researcher, I have often ...

"It has effectively resolved the perceived trade-off between rural employment, income growth and ecological protection," Wu ...

BY MOVING to a dual 5G network model, Malaysia has pivoted towards flexibility and resilience to drive long-term economic growth.

Jarrod Bowen Emerges as Summer TargetLiverpool’s summer rebuild is already taking shape, and fresh reporting from DaveOCKOP ...

Transaction expected to approximately triple NEXGEL’s annual revenue to approximately $35 million and is expected to be immediately accretive to ...

Dr. Cinik, opens new tab has officially launched a dedicated hair restoration clinic on London's prestigious Harley Street, ...

Bruce Power has entered into a collaboration agreement with Energy Alberta, under which Bruce Power will share its nuclear ...

ABU DHABI, 21st April, 2026 (WAM) -- M42 has announced the results of a national study conducted in partnership with the Department of Health – Abu Dhabi, highlighting the pivotal role of genomics in ...